UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 514

Sortiert nach

Pharmacokinetics and Metabolism of Melflufen, an Alkylating Peptide–Drug Conjugate, in Patients with Relapsed Refractory Multiple Myeloma

Journal of clinical pharmacology, 2024-02, Vol.64 (2), p.240-252

2024

Volltextzugriff (PDF)

Bioinformatic Tools and Genome Analysis of Citrus tristeza virus

Methods in molecular biology (Clifton, N.J.), 2019-01, Vol.2015, p.163

2019

Volltextzugriff (PDF)

The effect of gradually decreasing the dietary energy content, at constant or increased lysine:energy ratio on broiler performance, carcass yield, and body composition

Poultry science, 2022-11, Vol.101 (11), p.102132-102132, Article 102132

2022

Volltextzugriff (PDF)

Grapevine virus T diversity as revealed by full-length genome sequences assembled from high-throughput sequence data

PloS one, 2018-10, Vol.13 (10), p.e0206010-e0206010

2018

Volltextzugriff (PDF)

Population Pharmacokinetics of Glasdegib in Patients With Advanced Hematologic Malignancies and Solid Tumors

Journal of clinical pharmacology, 2020-05, Vol.60 (5), p.605-616

2020

Volltextzugriff (PDF)

The effect of reducing dietary calcium in prestarter diets (0–4 D) on growth performance of broiler chickens, tibia characteristics, and calcium and phosphorus concentration in blood

Poultry science, 2020-10, Vol.99 (10), p.4904-4913

2020

Volltextzugriff (PDF)

Application of bioelectrical impedance analysis to assess body composition of male and female broiler chickens from 2 different strains throughout the growth period

Poultry science, 2024-03, Vol.103 (3), p.103447-103447, Article 103447

2024

Volltextzugriff (PDF)

High-Throughput Sequencing Reveals Further Diversity of Little Cherry Virus 1 with Implications for Diagnostics

Viruses, 2018-07, Vol.10 (7), p.385

2018

Volltextzugriff (PDF)

Characterization of Neutropenia in Advanced Cancer Patients Following Palbociclib Treatment Using a Population Pharmacokinetic‐Pharmacodynamic Modeling and Simulation Approach

Journal of clinical pharmacology, 2017-09, Vol.57 (9), p.1159-1173

2017

Volltextzugriff (PDF)

Population pharmacokinetic model with time‐varying clearance for lorlatinib using pooled data from patients with non‐small cell lung cancer and healthy participants

CPT: pharmacometrics and systems pharmacology, 2021-02, Vol.10 (2), p.148-160

2021

Volltextzugriff (PDF)

Pharmacometric modeling and machine learning analyses of prognostic and predictive factors in the JAVELIN Gastric 100 phase III trial of avelumab

CPT: pharmacometrics and systems pharmacology, 2022-03, Vol.11 (3), p.333-347

2022

Volltextzugriff (PDF)

Characterization of the Relationship of Inotuzumab Ozogamicin Exposure With Efficacy and Safety End Points in Adults With Relapsed or Refractory Acute Lymphoblastic Leukemia

Clinical and translational science, 2021-01, Vol.14 (1), p.184-193

2021

Volltextzugriff (PDF)

Development and Validation of a Duplex RT-qPCR for Detection of Peach Latent Mosaic Viroid and Comparison of Different Nucleic-Acid-Extraction Protocols

Plants (Basel), 2023-04, Vol.12 (9), p.1802

2023

Volltextzugriff (PDF)

Complete Genome Characterization of Penicillimonavirus gammaplasmoparae, a Bipartite Member of the Family Mymonaviridae

Plants (Basel), 2023-09, Vol.12 (18), p.3300

2023

Volltextzugriff (PDF)

Pharmacometric dose optimization of buprenorphine in neonatal opioid withdrawal syndrome

Clinical and translational science, 2021-11, Vol.14 (6), p.2171-2183

2021

Volltextzugriff (PDF)

Application of Bioelectrical Impedance Analysis (BIA) to Assess Carcass Composition and Nutrient Retention in Rabbits from 25 to 77 Days of Age

Animals (Basel), 2022-10, Vol.12 (21), p.2926

2022

Volltextzugriff (PDF)

Lorlatinib Exposure‐Response Analyses for Safety and Efficacy in a Phase I/II Trial to Support Benefit–Risk Assessment in Non‐Small Cell Lung Cancer

Clinical pharmacology and therapeutics, 2021-11, Vol.110 (5), p.1273-1281

2021

Volltextzugriff (PDF)

Response to “Lorlatinib Exposed: A Far from Optimal Dose”

Clinical pharmacology and therapeutics, 2022-06, Vol.111 (6), p.1197-1198

2022

Volltextzugriff (PDF)

Impact of Drug Exposure on Resistance Selection Following Artemether‐Lumefantrine Treatment for Malaria in Children With and Without HIV in Uganda

Clinical pharmacology and therapeutics, 2023-03, Vol.113 (3), p.660-669

2023

Volltextzugriff (PDF)

Changes with age (from 0 to 37 D) in tibiae bone mineralization, chemical composition and structural organization in broiler chickens

Poultry science, 2019-11, Vol.98 (11), p.5215-5225

2019

Volltextzugriff (PDF)

Randomized Phase II Study of Dacomitinib (PF-00299804), an Irreversible Pan–Human Epidermal Growth Factor Receptor Inhibitor, Versus Erlotinib in Patients With Advanced Non–Small-Cell Lung Cancer

Journal of clinical oncology, 2012-09, Vol.30 (27), p.3337-3344

2012

Volltextzugriff (PDF)

Pharmacokinetic/Pharmacodynamic Modeling to Support the Re‐approval of Gemtuzumab Ozogamicin

Clinical pharmacology and therapeutics, 2019-11, Vol.106 (5), p.1006-1017

2019

Volltextzugriff (PDF)

Effect of feed restriction on performance, carcass yield and nitrogen and energy balance in growing rabbits

Livestock science, 2020-11, Vol.241, p.104278, Article 104278

2020

Volltextzugriff (PDF)

1 – 25 von 514

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(440)
Mit Volltextzugriff
(478)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Pharmacokinetics and Metabolism of Melflufen, an Alkylating Peptide–Drug Conjugate, in Patients with Relapsed Refractory Multiple Myeloma

Bioinformatic Tools and Genome Analysis of Citrus tristeza virus

The effect of gradually decreasing the dietary energy content, at constant or increased lysine:energy ratio on broiler performance, carcass yield, and body composition

Virus Detection by High-Throughput Sequencing of Small RNAs: Large-Scale Performance Testing of Sequence Analysis Strategies

Grapevine virus T diversity as revealed by full-length genome sequences assembled from high-throughput sequence data

Population Pharmacokinetics of Glasdegib in Patients With Advanced Hematologic Malignancies and Solid Tumors

The effect of reducing dietary calcium in prestarter diets (0–4 D) on growth performance of broiler chickens, tibia characteristics, and calcium and phosphorus concentration in blood

Application of bioelectrical impedance analysis to assess body composition of male and female broiler chickens from 2 different strains throughout the growth period

High-Throughput Sequencing Reveals Further Diversity of Little Cherry Virus 1 with Implications for Diagnostics

Characterization of Neutropenia in Advanced Cancer Patients Following Palbociclib Treatment Using a Population Pharmacokinetic‐Pharmacodynamic Modeling and Simulation Approach

Population pharmacokinetic model with time‐varying clearance for lorlatinib using pooled data from patients with non‐small cell lung cancer and healthy participants

Pharmacometric modeling and machine learning analyses of prognostic and predictive factors in the JAVELIN Gastric 100 phase III trial of avelumab

Characterization of the Relationship of Inotuzumab Ozogamicin Exposure With Efficacy and Safety End Points in Adults With Relapsed or Refractory Acute Lymphoblastic Leukemia

Development and Validation of a Duplex RT-qPCR for Detection of Peach Latent Mosaic Viroid and Comparison of Different Nucleic-Acid-Extraction Protocols

Complete Genome Characterization of Penicillimonavirus gammaplasmoparae, a Bipartite Member of the Family Mymonaviridae

Pharmacometric dose optimization of buprenorphine in neonatal opioid withdrawal syndrome

Application of Bioelectrical Impedance Analysis (BIA) to Assess Carcass Composition and Nutrient Retention in Rabbits from 25 to 77 Days of Age

Lorlatinib Exposure‐Response Analyses for Safety and Efficacy in a Phase I/II Trial to Support Benefit–Risk Assessment in Non‐Small Cell Lung Cancer

Response to “Lorlatinib Exposed: A Far from Optimal Dose”

Impact of Drug Exposure on Resistance Selection Following Artemether‐Lumefantrine Treatment for Malaria in Children With and Without HIV in Uganda

Changes with age (from 0 to 37 D) in tibiae bone mineralization, chemical composition and structural organization in broiler chickens

Randomized Phase II Study of Dacomitinib (PF-00299804), an Irreversible Pan–Human Epidermal Growth Factor Receptor Inhibitor, Versus Erlotinib in Patients With Advanced Non–Small-Cell Lung Cancer

A phase 2 trial of dacomitinib (PF‐00299804), an oral, irreversible pan‐HER (human epidermal growth factor receptor) inhibitor, in patients with advanced non–small cell lung cancer after failure of prior chemotherapy and erlotinib

Pharmacokinetic/Pharmacodynamic Modeling to Support the Re‐approval of Gemtuzumab Ozogamicin

Effect of feed restriction on performance, carcass yield and nitrogen and energy balance in growing rabbits

Suchergebnisse filtern